Wells Fargo & Company Roivant Sciences Ltd. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Wells Fargo & Company holds 16,652 shares of ROIV stock, worth $180,341. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,652
Previous 26,069
36.12%
Holding current value
$180,341
Previous $292,000
40.07%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ROIV
# of Institutions
265Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$791 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$751 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$723 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$392 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$386 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.63B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...